taurine has been researched along with Day Blindness in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate diabetic retinopathy (DR), plasma long pentraxin-3 (PTX-3) and taurine levels, and systemic factors in patients with type 2 diabetes mellitus (DM)." | 4.02 | New Insights into Diabetic and Vision-Threatening Retinopathy: Importance of Plasma Long Pentraxine 3 and Taurine Levels. ( Erdenen, F; Güngel, H; Kilic Muftuoglu, I; Ogreden, T; Pasaoglu, I; Sak, D, 2021) |
| "Vigabatrin is an irreversible inhibitor of γ-aminobutyric acid (GABA) transaminase." | 2.47 | Understanding and interpreting vision safety issues with vigabatrin therapy. ( Plant, GT; Sergott, RC, 2011) |
| "Taurine also ameliorated the visual impairments in the MNU-induced mice as evidenced by functional examinations." | 1.51 | Systemic taurine treatment provides neuroprotection against retinal photoreceptor degeneration and visual function impairments. ( Chen, W; He, M; Ma, Z; Peng, G; Qu, Y; Tao, Y; Teng, D; Yang, Q, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tao, Y | 1 |
| He, M | 1 |
| Yang, Q | 1 |
| Ma, Z | 1 |
| Qu, Y | 1 |
| Chen, W | 1 |
| Peng, G | 1 |
| Teng, D | 1 |
| Güngel, H | 1 |
| Erdenen, F | 1 |
| Pasaoglu, I | 1 |
| Sak, D | 1 |
| Ogreden, T | 1 |
| Kilic Muftuoglu, I | 1 |
| Plant, GT | 1 |
| Sergott, RC | 1 |
| Vinton, NE | 1 |
| Heckenlively, JR | 1 |
| Laidlaw, SA | 1 |
| Martin, DA | 1 |
| Foxman, SR | 1 |
| Ament, ME | 1 |
| Kopple, JD | 1 |
| Neuringer, M | 1 |
| Imaki, H | 1 |
| Sturman, JA | 1 |
| Moretz, R | 1 |
| Wisniewski, HM | 1 |
1 review available for taurine and Day Blindness
| Article | Year |
|---|---|
Understanding and interpreting vision safety issues with vigabatrin therapy.
Topics: 4-Aminobutyrate Transaminase; Adult; Animals; Anticonvulsants; Causality; Comorbidity; Confounding F | 2011 |
4 other studies available for taurine and Day Blindness
| Article | Year |
|---|---|
Systemic taurine treatment provides neuroprotection against retinal photoreceptor degeneration and visual function impairments.
Topics: Animals; Apoptosis; Disease Models, Animal; Female; Injections, Intraperitoneal; Injections, Intrave | 2019 |
New Insights into Diabetic and Vision-Threatening Retinopathy: Importance of Plasma Long Pentraxine 3 and Taurine Levels.
Topics: Aged; Aged, 80 and over; Blood Glucose; Blood Pressure; C-Reactive Protein; Cross-Sectional Studies; | 2021 |
Visual function in patients undergoing long-term total parenteral nutrition.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Electroretinography; Female; Humans; Infant; Linol | 1990 |
Abnormal visual acuity and retinal morphology in rhesus monkeys fed a taurine-free diet during the first three postnatal months.
Topics: Aging; Animals; Diet; Macaca mulatta; Microscopy, Electron; Retina; Taurine; Vision Disorders; Visua | 1987 |